Lion Street Advisors, LLC Cardiol Therapeutics Inc. Call Options Transaction History
Lion Street Advisors, LLC
- $317 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
42Shares Held
6.56MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$3.46 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$908,8310.22% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$310,6390.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$300,4801.46% of portfolio
-
Cambridge Investment Research Advisors, Inc.206KShares$218,6400.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $65.7M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...